Modified Rankin Scale

Abstract

The Modified Rankin Scale (mRS) is a widely recognized global assessment tool utilized primarily to quantify the degree of disability or dependence in individuals who have suffered a stroke (CVA) or other causes of neurological impairment. It functions as an observational scale, classifying patients into six distinct levels based on their functional status and ability to perform activities of daily living. Scores range from 0, indicating no symptoms whatsoever, up to 5, representing severe disability requiring constant nursing care and attention. An additional score of 6 is used to denote death.

Keywords

Modified Rankin Scale, mRS, Stroke outcome, Neurological assessment, Functional outcome, Disability, Observational scale, CVA.

Authors

Rankin J (1957), Modification: Bamford JM, et al. (1989), Dutch version: van Swieten JC, et al. (1988)

Purpose

The primary purpose of the Modified Rankin Scale is to provide a standardized, simple, and reliable measure of global functional outcome in patients, particularly those involved in clinical trials related to acute stroke intervention. Its ordinal nature allows clinicians and researchers to quickly categorize the level of independence a patient has achieved following a neurological event.

Historically, the scale was developed to assess general outcomes, but its modification and widespread adoption solidified its role as the gold standard outcome measure in stroke research. It measures the impact of the neurological deficit on the patient’s overall lifestyle, rather than simply measuring specific impairments.

Construct

The mRS measures the construct of global disability and dependence following a neurological insult. Unlike specific impairment scales (e.g., the NIH Stroke Scale), the mRS assesses the patient’s ability to function independently in their daily life. This includes mobility, self-care, and the ability to return to pre-stroke activities.

The scale assumes a linear progression of disability, where a higher score indicates greater dependence on others. The core focus is on the patient’s functional status and their capacity to live without assistance, making it a critical measure for determining the long-term efficacy of medical or rehabilitative interventions.

Validity

The validity of the Modified Rankin Scale is well-established, particularly its **predictive validity** concerning long-term outcome after stroke. Studies consistently show that mRS scores obtained early post-stroke are strong predictors of mortality and quality of life at three, six, and twelve months.

Furthermore, the scale demonstrates strong **construct validity**, correlating highly with other established measures of functional independence, such as the Barthel Index and the Glasgow Outcome Scale. The simplicity of its structure ensures that it captures the essential impact of the neurological event on the patient’s daily activities, confirming that it measures the intended construct of global disability.

Reliability

The reliability of the mRS is generally considered high, especially when administered by trained personnel using structured interview methodologies (like the mRS-I, or modified Rankin Scale Interview). **Inter-rater reliability** tends to be excellent to good, particularly when distinguishing between major categories (e.g., independent scores 0–2 vs. dependent scores 3–5). Discrepancies often arise in differentiating adjacent scores (e.g., 1 vs. 2) due to subjective interpretations of minor symptoms.

To maximize reliability, structured training and standardized interview protocols are mandatory for researchers and clinicians utilizing the scale, ensuring consistent scoring across different raters and clinical settings. The original simplicity of the scale is enhanced by these standardized approaches, maintaining its utility as a robust clinical and research tool.

Factor Analysis

As an **ordinal, single-item scale**, the Modified Rankin Scale does not typically undergo traditional factor analysis designed for multi-item psychometric instruments. However, its performance as an outcome measure is frequently analyzed. Research confirms that the mRS effectively represents a single underlying construct—global functional independence—which is paramount in the context of neurological recovery.

Instrument

Test Type: Observational scale / Clinical Interview

Format: Six-point ordinal scale (0 to 5, plus 6 for death)

Language Available: Originally English, widely translated (including Dutch version by van Swieten JC, et al.)

Population Group: Adults, Elderly

Age Group: 18+

Population Details: Individuals suffering from acute or chronic neurological conditions, primarily **stroke** (CVA) patients, and those with diseases affecting the nervous system and senses (Head/Neck region pathologies).

Test Methodology: Usually administered via a semi-structured interview, assessing the patient’s capacity for independent function over the preceding two weeks or specified time frame. The original PDF for the explanation form can be downloaded here: mRS-form.pdf. The original PDF for the measurement instrument can be downloaded here: mRS-meetinstr-KNGF.pdf.

Keywords

Activities of Daily Living, Outcome measure, Neurological recovery, Clinical trials, Dependence, Functional status, Acute care.

Authors

Author ORCID Identifier: N/A (Information not provided in source)

Affiliation Email addresses: N/A (Information not provided in source)

Correspondence Address: N/A (Information not provided in source)

Permissions & Fee and Test Year

The Modified Rankin Scale is a widely used clinical tool that is generally considered to be in the public domain for non-commercial clinical and research use, requiring no specific licensing fee. The original scale was published by **Rankin J in 1957**, with the crucial modification that established the current standard published by **Bamford JM, et al. in 1989**.

Reference’s

• Rankin J. Cerebral vascular accidents in patients over 60. II. Prognosis. Stroke. 1957; 2: 14–21.
• van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988; 19: 604–607.
• Bamford JM, Sandercock PA, Warlow CP, Gray MJ. Interobserver agreement for the assessment of severity and outcome in stroke. Stroke. 1989; 20: 828–829.

Items of the Modified Rankin Scale

IMPORTANT: The following scale items must be preserved in their original language and must not be changed in any way.

1. 0: No symptoms at all.
2. 1: No significant disability despite symptoms; able to carry out all usual duties and activities.
3. 2: Slight disability; unable to carry out all previous activities, but able to manage own affairs without assistance.
4. 3: Moderate disability; requiring some help, but able to walk without assistance.
5. 4: Moderately severe disability; unable to walk without assistance and unable to attend to own bodily needs without assistance.
6. 5: Severe disability; bedridden, incontinent, and requiring constant nursing care and attention.
7. 6: Dead.